Workflow
NeuroOne Medical Technologies (NMTC)
icon
Search documents
NeuroOne Medical Technologies (NMTC) - 2024 Q2 - Earnings Call Transcript
2024-05-15 01:48
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q2 2024 Earnings Conference Call May 14, 2024 4:30 PM ET Company Participants Dave Rosa - President & Chief Executive Officer Ron McClurg - Chief Financial Officer Conference Call Participants Operator Good day, ladies and gentlemen. Welcome to the NeuroOne Medical Technologies Corporation Second Quarter of Fiscal Year 2024 Financial Results Conference Call. Today's call will be conducted by the company's Chief Executive Officer, Dave Rosa; and Ron McC ...
NeuroOne Medical Technologies (NMTC) - 2024 Q2 - Quarterly Report
2024-05-14 20:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 For the Quarterly Period Ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number: 001-40439 NeuroOne Medical Technologies Corporation (Exact name of Registrant as specified in its charter) Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Delaware 27- ...
NeuroOne Medical Technologies (NMTC) - 2024 Q2 - Quarterly Results
2024-05-14 20:10
Exhibit 99.1 NeuroOneReports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update EDEN PRAIRIE, Minn., May 14, 2024 (GlobeNewswire) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces its operating results for the second quarter fiscal year 2024 ended March 31, 2024. Second Quarter Fiscal Yea ...
NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14
Newsfilter· 2024-05-10 18:43
EDEN PRAIRIE, Minn., May 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call and webcast on May 14, 2024 at 4:30 PM Eastern Time to discuss financial results for its second quarter of fiscal year 2024 ended March 31, 2024, and provide a corporate update. Conference Call and Webcast ...
NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14
GlobeNewsWire· 2024-05-10 18:43
EDEN PRAIRIE, Minn., May 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call and webcast on May 14, 2024 at 4:30 PM Eastern Time to discuss financial results for its second quarter of fiscal year 2024 ended March 31, 2024, and provide a corporate update. Conference Call and Webcast ...
NeuroOne Medical Technologies (NMTC) - 2024 Q1 - Earnings Call Transcript
2024-02-14 01:04
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q1 2024 Earnings Conference Call February 13, 2024 4:30 PM ET Company Participants Ron McClurg – Chief Financial Officer Conference Call Participants Operator Good day, ladies and gentlemen, and welcome to the NeuroOne Medical Technologies Corporation First Quarter of Fiscal Year 2024 Financial Results Conference Call. Today's call will be conducted by the company's Chief Financial Officer, Ron McClurg. Before I turn the call over to Mr. McClurg, I'd l ...
NeuroOne Medical Technologies (NMTC) - 2024 Q1 - Quarterly Report
2024-02-13 21:05
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number: 001-40439 NeuroOne Medical Technologies Corporation (Exact name of Registrant as specified in its charter) Delaware ...
NeuroOne Medical Technologies (NMTC) - 2023 Q4 - Annual Report
2023-12-15 21:39
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission file number 001-40439 NeuroOne Medical Technologies Corporation (Exact name of Registrant as specified in its charter) (State or other j ...
NeuroOne Medical Technologies (NMTC) - 2023 Q4 - Earnings Call Transcript
2023-12-14 23:30
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q4 2023 Results Conference Call December 14, 2023 5:00 PM ET Company Participants Dave Rosa - CEO Ron McClurg - CFO Conference Call Participants Ben Haynor - Alliance Global Partners Operator Ladies and gentlemen, thank you for standing by, and welcome to the NeuroOne Medical Technologies Corporation Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results Conference Call. Today's call will be conducted by the company's Chief Executive Officer ...
NeuroOne Medical Technologies (NMTC) - 2023 Q3 - Earnings Call Transcript
2023-08-14 23:26
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q3 2023 Results Conference Call August 14, 2023 4:30 PM ET Company Participants Dave Rosa - Chief Executive Officer Ron McClurg - Chief Financial Officer Operator Good day, ladies and gentlemen. Thank you for standing by. And welcome to the NeuroOne Medical Technologies Corporation Third Quarter Fiscal Year 2023 Financial Results Conference Call. Today's call will be conducted by the company's Chief Executive Officer, Dave Rosa; and the Chief Financial ...